مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,366
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

1,103
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

DOES MESENCHYMAL STEM CELL THERAPY HELP MULTIPLE SCLEROSIS PATIENTS? REPORT OF A PILOT STUDY

Pages

  50-57

Abstract

 Background: MESENCHYMAL STEM CELLS (MSCs) with their potential to differentiate into mesodermal and non-mesodermal lineages have several immunomodulatory characteristics. These properties make them promising tools in cell and gene therapy. Objective: To evaluate the potential therapeutic applications of autologous MSC in improving clinical manifestations of MS patients. Methods: Ten patients were included in this pilot study. All had progressive disease that had not responded to disease modifying agents including Mitoxantron. Their Expanded Disability Status Scale (EDSS) score ranged from 3 to 6. Patients were injected intrathecally with culture expanded MSCs. They were followed with monthly neurological assessment and a MRI scan at the end of the first year. Results: During 13 to 26 months of follow up (mean: 9 months), the EDSS of one patient improved from 5 to 2.5 score. Four patients showed no change in EDSS. Five patients’ EDSS increased from 0.5 to 2.5. In the functional system assessment, six patients showed some degree of improvement in their sensory, pyramidal, and cerebellar functions. One showed no difference in clinical assessment and three deteriorated. The result of MRI assessment after 12 months was as following: seven patients with no difference, two showed an extra plaque, and one patient showed decrease in the number of plaques. Conclusion: This preliminary report emphasizes on the feasibility of autologous MSC for treatment of MS patients. However, in order to draw a definitive conclusion a larger sample size is required.

Multimedia

  • No record.

    • Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    MOHY ALDIN BONAB, M., ALI MOGHADAM, K., GHAVAMZADEH, ARDESHIR, YAZDANBAKHSH, S., LOTFI, J., TALEBIAN, F., NIKBIN, B., & HOUSHMAND, F.. (2007). DOES MESENCHYMAL STEM CELL THERAPY HELP MULTIPLE SCLEROSIS PATIENTS? REPORT OF A PILOT STUDY. IRANIAN JOURNAL OF IMMUNOLOGY (IJI), 4(1), 50-57. SID. https://sid.ir/paper/296768/en

    Vancouver: Copy

    MOHY ALDIN BONAB M., ALI MOGHADAM K., GHAVAMZADEH ARDESHIR, YAZDANBAKHSH S., LOTFI J., TALEBIAN F., NIKBIN B., HOUSHMAND F.. DOES MESENCHYMAL STEM CELL THERAPY HELP MULTIPLE SCLEROSIS PATIENTS? REPORT OF A PILOT STUDY. IRANIAN JOURNAL OF IMMUNOLOGY (IJI)[Internet]. 2007;4(1):50-57. Available from: https://sid.ir/paper/296768/en

    IEEE: Copy

    M. MOHY ALDIN BONAB, K. ALI MOGHADAM, ARDESHIR GHAVAMZADEH, S. YAZDANBAKHSH, J. LOTFI, F. TALEBIAN, B. NIKBIN, and F. HOUSHMAND, “DOES MESENCHYMAL STEM CELL THERAPY HELP MULTIPLE SCLEROSIS PATIENTS? REPORT OF A PILOT STUDY,” IRANIAN JOURNAL OF IMMUNOLOGY (IJI), vol. 4, no. 1, pp. 50–57, 2007, [Online]. Available: https://sid.ir/paper/296768/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button